Follow
Evan Begg
Evan Begg
Professor of Medicine
Verified email at otago.ac.nz
Title
Cited by
Cited by
Year
Pharmacogenetics, drug-metabolizing enzymes, and clinical practice
SJ Gardiner, EJ Begg
Pharmacological reviews 58 (3), 521-590, 2006
5522006
Aminoglycosides--50 years on.
EJ Begg, ML Barclay
British journal of clinical pharmacology 39 (6), 597, 1995
4291995
Drugs in human milk: clinical pharmacokinetic considerations
HC Atkinson, EJ Begg, BA Darlow
Clinical pharmacokinetics 14, 217-240, 1988
2581988
Intratympanic versus intravenous delivery of methylprednisolone to cochlear perilymph
PA Bird, EJ Begg, M Zhang, AT Keast, DP Murray, TJ Balkany
Otology & Neurotology 28 (8), 1124-1130, 2007
2572007
A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated for major depression
RL Roberts, PR Joyce, RT Mulder, EJ Begg, MA Kennedy
The pharmacogenomics journal 2 (3), 191-196, 2002
2382002
A suggested approach to once‐daily aminoglycoside dosing.
EJ Begg, ML Barclay, SB Duffull
British journal of clinical pharmacology 39 (6), 605-609, 1995
2311995
Distribution and excretion of fluoxetine and norfluoxetine in human milk
Kristensen, Ilett, Hackett, Yapp, Paech, Begg
British journal of clinical pharmacology 48 (4), 521-527, 1999
2121999
Incidence and risk factors for hyponatraemia following treatment with fluoxetine or paroxetine in elderly people
TJ Wilkinson, EJ Begg, AC Winter, R Sainsbury
British journal of clinical pharmacology 47 (2), 211-217, 1999
2031999
The therapeutic monitoring of antimicrobial agents
EJ Begg, ML Barclay, CMJ Kirkpatrick
British Journal of Clinical Pharmacology 52 (S1), 35-43, 2001
1702001
Prediction of drug distribution into human milk from physicochemical characteristics
UC Atkinson, EJ Begg
Clinical pharmacokinetics 18, 151-167, 1990
1671990
Free drug metabolic clearance in elderly people
JM Butler, EJ Begg
Clinical Pharmacokinetics 47, 297-321, 2008
1572008
Once daily aminoglycoside therapy: is it less toxic than multiple daily doses and how should it be monitored?
ML Barclay, CMJ Kirkpatrick, EJ Begg
Clinical pharmacokinetics 36, 89-98, 1999
1501999
Adaptive resistance following single doses of gentamicin in a dynamic in vitro model
ML Barclay, EJ Begg, ST Chambers
Antimicrobial agents and chemotherapy 36 (9), 1951-1957, 1992
1501992
Studying drugs in human milk: time to unify the approach
EJ Begg, SB Duffull, LP Hackett, KF Ilett
Journal of Human Lactation 18 (4), 323-332, 2002
1382002
Intratympanic versus intravenous delivery of dexamethasone and dexamethasone sodium phosphate to cochlear perilymph
PA Bird, DP Murray, M Zhang, EJ Begg
Otology & Neurotology 32 (6), 933-936, 2011
1342011
What is the evidence for once-daily aminoglycoside therapy?
ML Barclay, EJ Begg, KG Hickling
Clinical pharmacokinetics 27, 32-48, 1994
1311994
Pharmacogenetic testing for drug metabolizing enzymes: is it happening in practice?
SJ Gardiner, EJ Begg
Pharmacogenetics and genomics 15 (5), 365-369, 2005
1192005
Transfer of olanzapine into breast milk, calculation of infant drug dose, and effect on breast-fed infants
SJ Gardiner, JH Kristensen, EJ Begg, LP Hackett, DA Wilson, KF Ilett, ...
American Journal of Psychiatry 160 (8), 1428-1431, 2003
1182003
Rapid and simple high-performance liquid chromatographic assay for the determination of metformin in human plasma and breast milk
M Zhang, GA Moore, M Lever, SJ Gardiner, CMJ Kirkpatrick, EJ Begg
Journal of Chromatography B 766 (1), 175-179, 2002
1172002
Exposure to thiopurine drugs through breast milk is low based on metabolite concentrations in mother‐infant pairs
SJ Gardiner, RB Gearry, RL Roberts, M Zhang, ML Barclay, EJ Begg
British journal of clinical pharmacology 62 (4), 453-456, 2006
1162006
The system can't perform the operation now. Try again later.
Articles 1–20